Oroxcell secures GLP certification
The GLP certification has been granted under the 2004/9/EU directive (safety testing) by the French Health and Safety Agency (Agence Francaise de Securite Sanitaire des Produits de Sante
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Boehringer obtains development and commercialisation rights to ZP2929 – Zealand Pharma’s glucagon/GLP-1 dual agonist drug candidate. Under the agreement, Zealand Pharma will be responsible for conducting the first